Job Purpose
This hybrid role is responsible for managing drug safety vendor oversight and safety operational activities, as well as contributing to safety surveillance for MoonLake products in clinical development. The individual will collaborate cross-functionally and work with external safety teams, ensuring adherence to global pharmacovigilance & GCP regulations, and ensuring inspection readiness.
Major Accountabilities
PV Operations & Vendor Oversight
Major Accountabilities
PV Operations & Vendor Oversight
- Setup/update Safety Management Plans (SMPs) & monitor safety vendor deliverables including ICSR and periodic report compliance.
- Maintain and monitor the quality of outsourced PV activities; ensure the activities are compliant with GVP, GCP and global regulatory requirements.
- Monitor KPI compliance of the vendor for the outsourced activities.
- In collaboration with safety vendor and internal/external Data Management groups, perform/oversee TMF filing/SAE reconciliation activities.
- Serve as Point of Contact for internal as well as external teams (e.g., safety vendor) on matters of clinical safety/PV audits/inspections.
- Oversee the preparation and review of documents used in GVP/GCP activities; present GVP activities during regulatory inspections.
- In collaboration with internal & external stakeholders, participate in and lead development & management of drug safety related CAPAs.
- Perform gap analysis; develop and/or update safety-related SOPs, processes and practices and ensure appropriate documentation for inspection/audit readiness.
- In collaboration with the Director of Drug Safety, participate in monitoring, review, analyses, interpretation and evaluation of incoming safety information (instream clinical study monitoring and aggregate safety data review); highlight potential safety signals.
- Contribute to the strategy and generation/review of safety assessments for signals or issues (including product quality); contribute to the development and maintenance of the development RMP.
- Lead the generation of aggregate safety reports (e.g., DSURs).
- Act as the safety representative in assigned clinical study teams, including providing safety input to study design, conduct, data analysis and interpretation.
- In partnership with the Director of Drug Safety, support presentation of important safety issues to the Drug Safety Committee (DSC) and other internal/external review and governance committees as needed.